1. A novel HLA‐B*37 allele, HLA‐B*37:58, identified in a Turkish family. (1st February 2016) Authors: Ibanez, C.; Marie‐Line, M.; Canivet, S.; Pellet, P.; Ba, I. Journal: HLA Issue: Volume 87:Number 2(2016) Page Start: 109 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Baseline sensitivity of T cells to alpha‐IFN correlates with sustained virological response to IFN‐based triple therapy in HCV infection. Issue 6 (10th November 2014) Authors: Sultanik, P.‐S.; Casrouge, A.; Alanio, C.; Mottez, E.; Rosa‐Hézode, I.; Hézode, C.; Renard, P.; Bousquet, L.; Pellet, P.; Uzé, G.; Pol, S.; Albert, M. L.; Mallet, V. Journal: Journal of viral hepatitis Issue: Volume 22:Issue 6(2015) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. (14th July 2021) Authors: Gottlieb, A.B.; Merola, J.F.; Reich, K.; Behrens, F.; Nash, P.; Griffiths, C.E.M.; Bao, W.; Pellet, P.; Pricop, L.; McInnes, I.B. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate‐to‐severe plaque psoriasis: results from EXCEED, a randomized, double‐blind head‐to‐head monotherapy study. (1st December 2021) Authors: Gottlieb, A.B.; Merola, J.F.; Reich, K.; Behrens, F.; Nash, P.; Griffiths, C.E.M.; Bao, W.; Pellet, P.; Pricop, L.; McInnes, I.B. Journal: British journal of dermatology Issue: Volume 185:Number 6(2021) Page Start: 1124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0340 COMPARISON OF SECUKINUMAB VERSUS ADALIMUMAB EFFICACY ON SKIN OUTCOMES IN PSORIATIC ARTHRITIS: 52-WEEK RESULTS FROM THE EXCEED STUDY. (2nd June 2020) Authors: Gottlieb, A. B.; Behrens, F.; Nash, P.; Merola, J. F.; Ding, K.; Pellet, P.; Pricop, L.; Mcinnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 763 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0227 SECUKINUMAB VERSUS ADALIMUMAB HEAD-TO-HEAD COMPARISON IN BIOLOGIC-NAÏVE PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS THROUGH 52-WEEKS (EXCEED): A RANDOMISED, DOUBLE-BLIND, PHASE-3B STUDY. (2nd June 2020) Authors: Mcinnes, I.; Behrens, F.; Mease, P. J.; Kavanaugh, A.; Ritchlin, C. T.; Nash, P.; Gratacos-Masmitja, J.; Goupille, P.; Korotaeva, T.; Gottlieb, A. B.; Martin, R.; Ding, K.; Pellet, P.; Mpofu, S.; Pricop, L. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 142 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. THU0373 SECUKINUMAB DOSE ESCALATION ON ACR RESPONSES IN ANTI-TUMOUR NECROSIS FACTOR NAÏVE PATIENTS WITH PSORIATIC ARTHRITIS: 2-YEAR DATA FROM THE PHASE 3 FUTURE 4 AND FUTURE 5 STUDIES. (2nd June 2020) Authors: Emery, P.; Ǿstergaard, M.; Coates, L. C.; Deodhar, A.; Quebe-Fehling, E.; Pellet, P.; Pricop, L.; Gaillez, C.; Van den Bosch, F. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗